Cellectis SA
CLLS · NYSE
$0.98+$0.005 (+0.51%)TodayMarket closed ·
Prev close $0.975
Who owns CLLS
Largest institutional holders, from their latest 13F filings
The 9 largest institutions hold 58.4% of CLLS’s shares.
- Astrazeneca Hldg BV44.0%
- Bpifrance Participations S.A.6.9%
- Choulika (André)2.3%
- Sourdive (David)1.7%
- Next 5 largest institutions3.5%
- All other shareholders41.6%
| Holder | Shares | % of shares |
|---|---|---|
| Astrazeneca Hldg BV | 31.69M | 43.96% |
| Bpifrance Participations S.A. | 4.98M | 6.91% |
| Choulika (André) | 1.69M | 2.34% |
| Sourdive (David) | 1.23M | 1.71% |
| Candriam Luxembourg S.A. | 1.21M | 1.68% |
| Caisse des Dépôts et Consignations | 1.04M | 1.44% |
| Montpensier Arbevel, S.A.S. | 183.51K | 0.25% |
| Saint Olive Gestion | 85.00K | 0.12% |
| Generali Insurance Asset Management S.p.A. SGR | 9.85K | 0.01% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Candriam Equities L Oncology | 957.34K | 1.33% |
| Belfius Equities Cure | 256.92K | 0.36% |
| MA Small Midcaps Europe | 183.51K | 0.25% |
| BSO Bio Santé | 85.00K | 0.12% |
| GF Europe | 9.85K | 0.01% |
Short interest
Settled Sep 30, 2026
- Shares short
- 351.33K
- Days to cover
- 2.30
- % of shares outstanding
- 0.49%
- Average daily volume
- 152.43K
- Change since last report
- −28.0%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.